Literature DB >> 29678901

WHO recommends additional tests for Sanofi's dengue vaccine after safety concerns.

Gareth Iacobucci1.   

Abstract

Year:  2018        PMID： 29678901     DOI： 10.1136/bmj.k1765

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Combination of Nonstructural Protein 1-Based Enzyme-Linked Immunosorbent Assays Can Detect and Distinguish Various Dengue Virus and Zika Virus Infections.

Authors:  Jasmine Tyson; Wen-Yang Tsai; Jih-Jin Tsai; Carlos Brites; Ludvig Mässgård; Han Ha Youn; Celia Pedroso; Jan Felix Drexler; Susan L Stramer; Angel Balmaseda; Eva Harris; Wei-Kung Wang
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Cross-reactive antibodies targeting surface-exposed non-structural protein 1 (NS1) of dengue virus-infected cells recognize epitopes on the spaghetti loop of the β-ladder domain.

Authors:  Romchat Kraivong; Somchoke Traewachiwiphak; Napon Nilchan; Nattaya Tangthawornchaikul; Nuntaya Pornmun; Ranyikar Poraha; Kanokwan Sriruksa; Wannee Limpitikul; Panisadee Avirutnan; Prida Malasit; Chunya Puttikhunt
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

3.  Dengue outbreaks in Hawai'i After WWII - A Review of Public Health Response and Scientific Literature.

Authors:  Rachel J Lew; Wen-Yang Tsai; Wei-Kung Wang
Journal:  Hawaii J Med Public Health       Date:  2018-12

Review 4.  Cross-reactive dengue virus-derived monoclonal antibodies to Zika virus envelope protein: Panacea or Pandora's box?

Authors:  Shannon A Gunawardana; Robert H Shaw
Journal:  BMC Infect Dis       Date:  2018-12-10       Impact factor: 3.090

5.  Epidemiological and clinical characteristics of Dengue virus outbreaks in two regions of China, 2014 - 2015.

Authors:  Jiaqi Cao; Hong Deng; Lei Ye; Xuezheng Ma; Shuru Chen; Xiaohong Sun; Xuemin Wu; Tao Yan; Liping Zhang; Lijuan Liu; Lili Li; Wuping Li; Kongxin Hu
Journal:  PLoS One       Date:  2019-03-05       Impact factor: 3.240

6.  Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II.

Authors:  Jih-Jin Tsai; Ching-Kuan Liu; Wen-Yang Tsai; Li-Teh Liu; Jasmine Tyson; Ching-Yi Tsai; Ping-Chang Lin; Wei-Kung Wang
Journal:  PLoS Negl Trop Dis       Date:  2018-10-24

7.  Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype.

Authors:  Stefan W Metz; Ashlie Thomas; Alex Brackbill; Yi Xianwen; Michele Stone; Katie Horvath; Michael J Miley; Chris Luft; Joseph M DeSimone; Shaomin Tian; Aravinda M de Silva
Journal:  PLoS Negl Trop Dis       Date:  2018-09-24

8.  Efficient Plant Production of Recombinant NS1 Protein for Diagnosis of Dengue.

Authors:  Mariana Fonseca Xisto; Roberto Sousa Dias; Elias Feitosa-Araujo; John Willians Oliveira Prates; Cynthia Canedo da Silva; Sérgio Oliveira de Paula
Journal:  Front Plant Sci       Date:  2020-10-26       Impact factor: 5.753
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.